Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Technology | 13.71% |
| 3 | Financials | 10.21% |
| 4 | Industrials | 9.72% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Semtech
SMTC
$13.2B
| $44.3M | 0.05% |
1,294,416
+60,200
| +5% | +$2.25M |
|
|
LMNX
502
DELISTED
Luminex Corp
LMNX
| $44.3M | 0.05% |
2,246,640
+334,900
| +18% | +$6.97M |
|
503
Huntsman Corp
HUN
$1.78B
| $44.1M | 0.05% |
1,325,300
+627,000
| +90% | +$19.2M |
|
504
Henry Schein
HSIC
$10.1B
| $43.9M | 0.05% |
800,333
+789,098
| +7,024% | +$45.8M |
|
|
AUO
505
DELISTED
AU Optronics Corp
AUO
| $43.9M | 0.05% |
10,543,384
+356,600
| +4% | +$1.48M |
|
|
PARA
506
DELISTED
Paramount Global Class B
PARA
| $43.8M | 0.05% |
742,600
+415,800
| +127% | +$23.9M |
|
507
Northwest Bancshares
NWBI
$2.3B
| $43.7M | 0.05% |
2,611,900
+74,600
| +3% | +$1.25M |
|
508
Central Garden & Pet Co Class A
CENTA
$2.42B
| $43.4M | 0.05% |
1,438,875
+73,750
| +5% | +$2.18M |
|
|
KEM
509
DELISTED
KEMET Corporation
KEM
| $43.4M | 0.05% |
2,880,200
-1,203,699
| -29% | -$22.9M |
|
510
REX American Resources
REX
$1.44B
| $43.3M | 0.05% |
3,136,200
-15,000
| -0.5% | -$220K |
|
|
SPR
511
DELISTED
Spirit AeroSystems
SPR
| $43.2M | 0.05% |
495,000
-157,300
| -24% | -$12.9M |
|
|
CCF
512
DELISTED
Chase Corporation
CCF
| $43.1M | 0.05% |
357,900
-2,100
| -0.6% | -$249K |
|
|
CARB
513
DELISTED
Carbonite Inc
CARB
| $43.1M | 0.05% |
1,716,100
-146,900
| -8% | -$3.41M |
|
514
Sabesp
SBS
$17.9B
| $43M | 0.05% |
21,228,372
+2,823,088
| +15% | +$5.42M |
|
515
US Physical Therapy
USPH
$1.21B
| $43M | 0.05% |
594,974
-113,700
| -16% | -$7.76M |
|
|
TWTR
516
DELISTED
Twitter, Inc.
TWTR
| $42.9M | 0.05% |
+1,787,500
| New | +$36.7M |
|
517
RE/MAX Holdings
RMAX
$264M
| $42.9M | 0.05% |
884,500
+132,400
| +18% | +$7.57M |
|
518
Thomson Reuters
TRI
$44.2B
| $42.8M | 0.05% |
846,101
-540,480
| -39% | -$28.3M |
|
519
Crocs
CROX
$6.22B
| $42.8M | 0.05% |
3,386,564
+447,624
| +15% | +$4.8M |
|
520
Church & Dwight Co
CHD
$24.2B
| $42.7M | 0.05% |
851,000
-828,900
| -49% | -$38.9M |
|
521
Bunge Global
BG
$21.5B
| $42.5M | 0.05% |
633,600
+506,318
| +398% | +$34.4M |
|
522
Scotiabank
BNS
$110B
| $42.1M | 0.05% |
652,600
-52,800
| -7% | -$3.42M |
|
523
Teck Resources
TECK
$32.7B
| $42.1M | 0.05% |
1,608,476
+415,600
| +35% | +$9.47M |
|
524
EXL Service
EXLS
$5.24B
| $42.1M | 0.05% |
3,485,000
+42,825
| +1% | +$523K |
|
525
Progress Software
PRGS
$1.76B
| $42.1M | 0.05% |
988,000
+298,000
| +43% | +$12.4M |
|
Similar funds
Jim Simons's Q4 2017 Portfolio in Review
As of Q4 2017, Jim Simons held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Jim Simons's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Jim Simons added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Jim Simons's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Jim Simons fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Jim Simons's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Jim Simons opened 521 new positions and closed 386 in Q4 2017.
- Jim Simons's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.